cosentyx
(secukinumab)Novartis Pharmaceuticals Corporation
Usage: COSENTYX is indicated for treating moderate to severe plaque psoriasis in patients 6 years and older, active psoriatic arthritis from age 2, adult ankylosing spondylitis, active non-radiographic axial spondyloarthritis, active enthesitis-related arthritis in patients 4 years and older, and moderate to severe hidradenitis suppurativa in adults.